查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1469294

全球防褥疮设备市场：依产品类型、最终用户、地区：产业分析、规模、占有率、成长、趋势、预测（2024-2032）

Pressure Ulcer Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 465 Pages | 商品交期: 2-5个工作天内

价格
简介目录

持久性市场研究全面分析了全球抗褥疮设备市场，并提供了有关市场动态、成长动力、课题和新兴趋势的重要见解。 该报告提供了独家数据和统计数据，以预测 2024 年至 2032 年褥疮控制设备市场的轨迹。

预估2024年全球压疮预防装置市场规模将达55亿美元，市场规模稳定扩张，复合年增长率为5.5%，预计2032年底产业估值将达84亿美元。

关键见解

  • 褥疮预防设备市场规模（2024 年）：55 亿美元
  • 预计市值（2032 年）：84 亿美元
  • 全球市场成长率（2024-2032）：5.5%

褥疮预防器市场-调查范围：

褥疮防护装置对于预防和治疗褥疮（也称为压疮或褥疮）至关重要。 这些设备包括床垫、靠垫、覆盖物和特殊床，旨在重新分配身体压力、减少摩擦和控制水分以防止压疮的发生。 该市场包括适用于各种医疗保健环境的各种产品，包括医院、疗养院和家庭护理。

全球压疮预防设备市场主要是由久坐不动、糖尿病和肥胖等慢性病盛行率不断上升所推动的，这些疾病增加了压疮发生的风险。 此外，世界人口老化也促使对压疮预防和管理解决方案的需求不断增长。 压力分布方面的技术进步，例如交变压力床垫和低空气损失床垫，透过提高患者舒适度和预防压疮的有效性，进一步推动市场成长。

推动市场成长的因素：

人口老化是市场成长的主要动力，因为老年人由于运动能力下降、皮肤变薄和併发症等因素更容易患压疮。 全球范围内老年人口比例不断增加，尤其是在已开发地区，对压疮预防和管理设备的需求预计将急剧增加。

此外，医疗基础设施的进步和医护人员对压疮预防意识的提高也有助于市场的扩张。 医疗机构越来越多地投资于先进的压力分布表面，以改善患者的治疗效果并减轻与压疮治疗相关的经济负担。

市场限制因素：

防褥疮装置市场面临的主要课题之一是与先进的防褥疮洩压表面相关的高成本。 儘管这些设备具有出色的压疮预防和管理功能，但其高昂的初始成本可能会阻碍其采用，特别是在预算有限的医疗机构中。

此外，某些地区压疮预防设备的报销政策不佳也阻碍了市场成长。 压疮预防和管理产品的保险范围有限，导致患者无力负担并阻碍了市场渗透。

市场机会：

对家庭医疗保健的日益关注和远距医疗的兴起为压疮预防设备市场提供了巨大的机会。 随着医疗保健服务转向更加分散的环境，对便携式且易于家庭使用的压力分布表面的需求不断增加。 製造商可以利用这一趋势，开发适合家庭照顾者和患者需求的创新产品。

此外，将感测器和连接等智慧技术整合到压疮控制设备中，为远端监控和数据驱动护理打开了大门。 具有监控功能的智慧压力分布表面使医疗保健提供者能够追踪患者的依从性、评估风险因素并主动干预以改善临床结果并减少再入院。

本报告涵盖的主要问题

  • 哪些地区对压疮预防设备的需求最大？
  • 压疮预防与管理策略的趋势是什么？
  • 监管架构如何影响全球压疮控制设备的采用？
  • 推动压疮预防设备领域技术创新与市场拓展的主要公司有哪些？
  • 塑造压疮预防设备市场未来的新科技趋势为何？

目录

第 1 章执行摘要

第二章市场概述

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包含和排除

第三章主要市场趋势

  • 影响市场的主要趋势
  • 产品创新/发展趋势

第 4 章增值见解

  • 依地区划分的洩压装置采用状况分析
  • 依国家/地区划分的疾病流行病学
  • 製造商的主要行销和促销策略
  • 价值链分析
  • 监管场景
  • 报销情况
  • 杵分析
  • 波特的分析

第 5 章具体见解

  • 目前 PU 预防方法：依最终使用者环境（急诊室/急诊/ICU/HDU/手术室/照护设施/长期照护/居家照护环境）
  • 敷料在预防压疮方面的作用
  • 亚太国家预防压疮的证据与照护标准
  • 当前预防压疮的课题
  • 各地区压疮预防的主要趋势

第六章市场背景

  • 宏观经济因素
  • 预测因子 - 相关性和影响
  • 市场动态

第 7 章 COVID-19 危机分析

  • 目前的 COVID-19 统计数据和未来的潜在影响
  • 当前 GDP 预测与预期影响
  • 新冠肺炎 (COVID-19) 与影响分析
    • 依地区
    • 依产品
    • 依阶段
    • 依最终用户

第 8 章全球压疮预防装置市场 - 价格分析

  • 以产品划分的区域价格分析
  • 世界平均价格分析基准

第九章全球压疮预防装置市场需求（数量）分析（2019-2023）及预测（2024-2032）

  • 过去的市场规模分析（2019-2023 年）
  • 目前与未来的市场规模预测（2024-2032 年）
    • 年成长趋势分析
    • 绝对利润机会分析

第10章全球压疮预防装置市场需求（数量或规模）分析（2019-2023）与预测（2024-2032）

  • 过往市值分析（2019-2023 年）
  • 当前与未来市场价值的预测（2024-2032 年）
    • 年成长趋势分析

第11章全球压疮预防装置市场分析（2019-2023）与预测（2024-2032）：依产品

  • 简介/主要发现
  • 过去的市场规模分析：依产品（2019-2023 年）
  • 目前与未来的市场规模预测：依产品分类（2024-2032 年）
    • 床垫覆盖层
    • 减压床垫
    • 特殊床
    • 减压垫
    • 交流压力轮椅垫
    • 越野设备
    • 洩压配件
    • 先进的伤口敷料
  • 依产品划分的市场吸引力分析

第十二章全球压疮预防装置市场分析（2019-2023）与预测（2024-2032）：依阶段

  • 简介/主要发现
  • 过去的市场规模分析：以阶段（2019-2023 年）
  • 目前/未来市场规模分析/预测：依阶段（2024-2032 年）
    • 第一阶段
    • 第二阶段
    • 第三阶段
    • 第四阶段
  • 分阶段市场吸引力分析

第 13 章 全球压疮预防装置市场分析（2019-2023 年）与预测（2024-2032 年）：依最终使用者划分

  • 简介/主要发现
  • 过去的市场规模分析：以最终用户划分（2019-2023 年）
  • 当前和未来的市场规模分析和预测：依最终用户划分（2024-2032 年）
    • 医院
    • 长期照护中心
    • 护理设施
    • 居家照护环境
  • 最终用户的市场吸引力分析

第14章依地区划分的全球压疮预防装置市场分析（2019-2023年）及预测（2024-2032年）

  • 简介
  • 过去的市场规模分析：依地区划分（2019-2023 年）
  • 目前与未来的市场规模分析与预测：依地区划分（2024-2032 年）
    • 北美
    • 拉丁美洲
    • 欧洲
    • 南亚
    • 东亚
    • 大洋洲
    • 中东和非洲 (MEA)
  • 依地区划分的市场吸引力分析

第十五章北美压疮预防装置市场分析（2019-2023）与预测（2024-2032）

第十六章拉丁美洲压疮预防装置市场（2019-2023）与预测（2024-2032）

第十七章欧洲压疮预防装置市场（2019-2023）与预测（2024-2032）

第十八章南亚压疮预防装置市场（2019-2023）与预测（2024-2032）

第十九章东亚压疮预防装置市场（2019-2023）与预测（2024-2032）

第20章大洋洲压疮预防装置市场（2019-2023）与预测（2024-2032）

第21章中东与非洲压疮预防装置市场（2019-2023年）与预测（2024-2032年）

第22章国家级压疮预防装置市场分析（2022年及2032年）

  • 简介
    • 主要国家市值比例分析
    • 世界与国家成长比较
  • 美国压疮预防设备市场分析
  • 加拿大压疮预防装置市场分析
  • 墨西哥压疮预防装置市场分析
  • 巴西压疮预防装置市场分析
  • 德国压疮预防装置市场分析
  • 义大利压疮预防装置市场分析
  • 法国压疮预防装置市场分析
  • 英国压疮预防装置市场分析
  • 西班牙压疮预防装置市场分析
  • 比荷卢经济联盟褥疮预防装置市场分析
  • 俄罗斯压疮预防装置市场分析
  • 中国压疮预防装置市场分析
  • 日本压疮预防装置市场分析
  • 韩国压疮预防装置市场分析
  • 印度压疮预防装置市场分析
  • 泰国的褥疮安防设备市场分析
  • 印尼压疮预防装置市场分析
  • 马来西亚压疮预防装置市场分析
  • 澳洲压疮预防装置市场分析
  • 纽西兰压疮预防装置市场分析
  • 海湾合作委员会国家压疮预防装置的市场分析
  • 土耳其压疮预防装置市场分析
  • 北非褥疮预防装置市场分析
  • 南非压疮预防装置市场分析

第23章市场结构分析

  • 依公司层级进行市场分析
  • 主要公司市占率分析
  • 市场现况分析

第 24 章竞争分析

  • 竞争对手仪表板
  • 竞争基准
  • 对竞争对手的深入分析
    • Stryker Corp.
    • Smith &Nephew Plc.
    • Hill-Rom Services Inc.
    • Paramount Bed Holdings Co., Ltd.
    • ArjoHuntleigh
    • Talley Group Limited
    • Drive DeVilbiss Healthcare Ltd（Sidhil Limited）
    • Apex Medical Corp.
    • Medtronic
    • PROMA REHA, sro
    • Linet spol. S RO
    • DARCO International
    • DeRoyal Industries
    • BSN Medical（Essity）
    • Molnlycke Health Care
    • TrueKAST（Wound Kair Concepts）
    • Thuasne SAS
    • DJO Global
    • ORTHOSERVICE AG
    • Breg, Inc.
    • Advanced Orthopaedics
    • ALGEOS
    • Hollister Incorporated
    • ConvaTec Group plc
    • Coloplast A/S
    • Medline Industries Inc.
    • Invacare Corporation

第 25 章先决条件与使用的缩写

第26章研究方法

简介目录
Product Code: PMRREP32831

Persistence Market Research offers a comprehensive analysis of the global pressure ulcer devices market, providing key insights into market dynamics, growth drivers, challenges, and emerging trends. This report offers exclusive data and statistics forecasting the trajectory of the pressure ulcer devices market from 2024 to 2032.

Revenue from the global pressure ulcer devices market reached US$ 5.5 Bn in 2024. With the market projected to expand at a steady 5.5% CAGR, industry valuation is set to top US$ 8.4 Bn by the end of 2032.

Key Insights:

  • Pressure Ulcer Devices Market Size (2024): US$ 5.5 Bn
  • Projected Market Value (2032):US$ 8.4 Bn
  • Global Market Growth Rate (2024-2032):5.5%

Pressure Ulcer Devices Market - Report Scope:

Pressure ulcer devices are essential in preventing and managing pressure ulcers, also known as bedsores or pressure sores, which commonly occur in individuals with limited mobility. These devices include mattresses, cushions, overlays, and specialty beds designed to redistribute pressure, reduce friction, and manage moisture, thus preventing the development of pressure ulcers. The market encompasses a wide range of products catering to various healthcare settings, including hospitals, nursing homes, and home care.

The global pressure ulcer devices market is primarily driven by the increasing prevalence of chronic conditions such as immobility, diabetes, and obesity, which elevate the risk of pressure ulcer development. Additionally, the growing aging population worldwide contributes to the rising demand for pressure ulcer prevention and management solutions. Technological advancements in pressure redistribution surfaces, such as alternating pressure mattresses and low-air-loss mattresses, further fuel market growth by enhancing patient comfort and efficacy in pressure ulcer prevention.

Market Growth Drivers:

The aging population demographic is a significant driver of market growth, as elderly individuals are more susceptible to pressure ulcer development due to factors such as reduced mobility, thinning skin, and comorbidities. With a globally increasing proportion of elderly individuals, particularly in developed regions, the demand for pressure ulcer prevention and management devices is expected to surge.

Moreover, advancements in healthcare infrastructure and increased awareness regarding pressure ulcer prevention among healthcare providers contribute to market expansion. Healthcare facilities are increasingly investing in advanced pressure redistribution surfaces to improve patient outcomes and reduce the economic burden associated with pressure ulcer treatment.

Market Restraints:

One of the key challenges faced by the pressure ulcer devices market is the high cost associated with advanced pressure redistribution surfaces. While these devices offer superior pressure ulcer prevention and management capabilities, their high upfront costs can deter adoption, particularly in healthcare settings with budget constraints.

Additionally, inadequate reimbursement policies for pressure ulcer prevention devices in certain regions hinder market growth. Limited insurance coverage for pressure ulcer prevention and management products reduces their affordability for patients, thereby limiting market penetration.

Market Opportunities:

The growing focus on home-based healthcare and the rise of telemedicine present significant opportunities for the pressure ulcer devices market. As healthcare delivery shifts towards decentralized settings, there is a heightened demand for portable and user-friendly pressure redistribution surfaces suitable for home use. Manufacturers can capitalize on this trend by developing innovative products tailored to the needs of home caregivers and patients.

Furthermore, the integration of smart technologies such as sensors and connectivity features into pressure ulcer devices opens up avenues for remote monitoring and data-driven care. Smart pressure redistribution surfaces equipped with monitoring capabilities enable healthcare providers to track patient compliance, assess risk factors, and intervene proactively, thereby improving clinical outcomes and reducing hospital readmissions.

Key Questions Answered in the Report:

  • Which regions are poised to exhibit the highest demand for pressure ulcer devices?
  • What are the prevailing trends in pressure ulcer prevention and management strategies?
  • How do regulatory frameworks impact the adoption of pressure ulcer devices globally?
  • Who are the key players driving innovation and market expansion in the pressure ulcer devices segment?
  • What are the emerging technological trends shaping the future of the pressure ulcer devices market?

Competitive Intelligence and Business Strategy:

Leading players in the pressure ulcer devices market focus on product innovation, strategic collaborations, and geographical expansion to maintain their competitive edge. Companies invest in research and development to introduce advanced features such as pressure sensing technology, temperature regulation, and antimicrobial properties in their products, enhancing their clinical efficacy and market appeal.

Key Companies Profiled:

  • Stryker Corp.
  • Smith & Nephew Plc.
  • Hill-Rom Services Inc.
  • Paramount Bed Holdings Co., Ltd.
  • ArjoHuntleigh
  • Talley Group Limited
  • Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
  • Apex Medical Corp.
  • Medtronic
  • PROMA REHA, s. r. o.
  • Linet spol. S R.O.
  • DARCO International
  • DeRoyal Industries
  • BSN Medical (Essity)
  • Molnlycke Health Care
  • TrueKAST (Wound Kair Concepts)
  • Thuasne SAS
  • DJO Global
  • ORTHOSERVICE AG
  • Breg, Inc.
  • Advanced Orthopaedics
  • ALGEOS
  • Hollister Incorporated
  • ConvaTec Group plc
  • Coloplast A/S
  • Medline Industries Inc.
  • Invacare Corporation

Pressure Ulcer Devices Market Research Segmentation:

Pressure Ulcer Devices Market by Product:

  • Mattress Overlays
  • Pressure Relief Mattresses

oFoam-based Mattress

oGel-based Mattress

oFiber-filled Mattress

oWater/Fluid-filled Mattress

oAir-filled Mattress

  • Speciality Beds

oKinetic Beds

oAir-Fluidized Beds

  • Pressure Relief Cushions
  • Alternating Pressure Wheelchair's Cushions
  • Off-Loading Devices

oTotal Contact Casting Systems

§Casting System with Boots

§Casting System without Boot

oOff-loading Shoes

§Post-Operative Offloading Shoes

§Wedge-based Shoes

§All Purpose Shoes

§Off-loading insoles

  • Pressure Relief Accessories
  • Advanced Wound Dressings

oAlginate Dressings

oCollagens Dressings

oFilms Dressing

oFoam Dressings

§Anti-microbial Foam Dressing

§Non-Anti-Microbial Foam Dressing

oHydrocolloids Dressing

oHydrofibers Dressings

oHydrogels Dressings

oSuperabsorbent Dressing

oWound Contact Layers

Pressure Ulcer Devices Market by Stage:

  • Stage I Pressure Ulcer Devices
  • Stage II Pressure Ulcer Devices
  • Stage III Pressure Ulcer Devices
  • Stage IV Pressure Ulcer Devices

Pressure Ulcer Devices Market by End User:

  • Hospitals
  • Long-term Care Centres
  • Skilled Nursing Facilities
  • Home Care Settings

Pressure Ulcer Devices Market by Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Value Added Insights

  • 4.1. Pressure Relief Devices Adoption Analysis, By Region
  • 4.2. Disease Epidemiology, By Country
  • 4.3. Key Marketing & Promotional Strategies, By Manufacturers
  • 4.4. Value Chain Analysis
  • 4.5. Regulatory Scenario
  • 4.6. Reimbursement Landscape
  • 4.7. PESTLE Analysis
  • 4.8. Porter's Analysis

5. Specific Insights

  • 5.1. Current PU Prevention Modalities, By End User Settings (ED/Acute Care/ICU's/HDU's/Operating Theatre/Nursing Facilities/Long Term Care/Home Care Settings)
  • 5.2. Role of dressings in pressure ulcer Prevention
  • 5.3. Evidences & Standard of Care of PU preventions, By Setting in Asia Pacific countries
  • 5.4. Current challenges in PU prevention
  • 5.5. Key Trends in PU Prevention, by region

6. Market Background

  • 6.1. Macro-Economic Factors
    • 6.1.1. Global GDP Growth Outlook
    • 6.1.2. Global Healthcare Outlook
  • 6.2. Forecast Factors - Relevance & Impact
    • 6.2.1. Hospital Bed Capacity Per Facility, by Country
    • 6.2.2. Lifespan of Hospital Equipment, Replacement Cycle and New Sales
    • 6.2.3. Adoption of Devices
    • 6.2.4. Prevalence of Pressure Ulcer
    • 6.2.5. Average Cost of Treatment
  • 6.3. Market Dynamics
    • 6.3.1. Drivers
    • 6.3.2. Restraints
    • 6.3.3. Opportunity Analysis

7. COVID19 Crisis Analysis

  • 7.1. Current COVID19 Statistics and Probable Future Impact
  • 7.2. Current GDP Projection and Probable Impact
  • 7.3. COVID19 and Impact Analysis
    • 7.3.1. By Region
    • 7.3.2. By Product
    • 7.3.3. By Stages
    • 7.3.4. By End User

8. Global Pressure Ulcer Devices Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Global Average Pricing Analysis Benchmark

9. Global Pressure Ulcer Devices Market Demand (Volume in thousand units) Analysis 2019-2023 and Forecast, 2024-2032

  • 9.1. Historical Market Volume (Thousand Units) Analysis, 2019-2023
  • 9.2. Current and Future Market Volume (Thousand Units) Projections, 2024-2032
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Pressure Ulcer Devices Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

  • 10.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 10.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
    • 10.2.1. Y-o-Y Growth Trend Analysis

11. Global Pressure Ulcer Devices Market Analysis 2019-2023 and Forecast 2024-2032, by Product

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) and Forecast By Product, 2024-2032
    • 11.3.1. Mattress Overlays
    • 11.3.2. Pressure Relief Mattresses
      • 11.3.2.1. Foam-based Mattress
      • 11.3.2.2. Gel-based Mattress
      • 11.3.2.3. Fiber-filled Mattress
      • 11.3.2.4. Water/Fluid-filled Mattress
      • 11.3.2.5. Air-filled Mattress
    • 11.3.3. Speciality Beds
      • 11.3.3.1. Kinetic Beds
      • 11.3.3.2. Air-Fluidized Beds
    • 11.3.4. Pressure Relief Cushions
    • 11.3.5. Alternating Pressure Wheelchair's Cushions
    • 11.3.6. Off-Loading Devices
      • 11.3.6.1. Total Contact Casting Systems
        • 11.3.6.1.1. Casting System with Boots
        • 11.3.6.1.2. Casting System without Boot
      • 11.3.6.2. Off-loading Shoes
        • 11.3.6.2.1. Post-Operative Offloading Shoes
        • 11.3.6.2.2. Wedge-based Shoes
        • 11.3.6.2.3. All Purpose Shoes
        • 11.3.6.2.4. Off-loading insoles
    • 11.3.7. Pressure Relief Accessories
    • 11.3.8. Advanced Wound Dressings
      • 11.3.8.1. Alginate Dressings
      • 11.3.8.2. Collagens Dressings
      • 11.3.8.3. Films Dressing
      • 11.3.8.4. Foam Dressings
        • 11.3.8.4.1. Anti-microbial Foam Dressing
        • 11.3.8.4.2. Non-Anti-Microbial Foam Dressing
      • 11.3.8.5. Hydrocolloids Dressing
      • 11.3.8.6. Hydrofibers Dressings
      • 11.3.8.7. Hydrogels Dressings
      • 11.3.8.8. Superabsorbent Dressing
      • 11.3.8.9. Wound Contact Layers
  • 11.4. Market Attractiveness Analysis By Product

12. Global Pressure Ulcer Devices Market Analysis 2019-2023 and Forecast 2024-2032, by Stages

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis by Stages, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Stages, 2024-2032
    • 12.3.1. Stage I
    • 12.3.2. Stage II
    • 12.3.3. Stage III
    • 12.3.4. Stage IV
  • 12.4. Market Attractiveness Analysis By Stages

13. Global Pressure Ulcer Devices Market Analysis 2019-2023 and Forecast 2024-2032, by End User

  • 13.1. Introduction / Key Findings
  • 13.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2032
    • 13.3.1. Hospitals
    • 13.3.2. Long-term Care Centres
    • 13.3.3. Skilled Nursing Facilities
    • 13.3.4. Home Care Settings
  • 13.4. Market Attractiveness Analysis by End User

14. Global Pressure Ulcer Devices Market Analysis 2019-2023 and Forecast 2024-2032, by Region

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2032
    • 14.3.1. North America
    • 14.3.2. Latin America
    • 14.3.3. Europe
    • 14.3.4. South Asia
    • 14.3.5. East Asia
    • 14.3.6. Oceania
    • 14.3.7. Middle East and Africa (MEA
  • 14.4. Market Attractiveness Analysis by Region

15. North America Pressure Ulcer Devices Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. U.S.
      • 15.3.1.2. Canada
    • 15.3.2. By Product
    • 15.3.3. By Stages
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Stages
    • 15.4.4. By End User
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis

16. Latin America Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. Brazil
      • 16.3.1.2. Mexico
      • 16.3.1.3. Rest of Latin America
    • 16.3.2. By Product
    • 16.3.3. By Stages
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Stages
    • 16.4.4. By End User
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis

17. Europe Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. Germany
      • 17.3.1.2. Italy
      • 17.3.1.3. France
      • 17.3.1.4. U.K.
      • 17.3.1.5. Spain
      • 17.3.1.6. BENELUX
      • 17.3.1.7. Russia
      • 17.3.1.8. Rest of Europe
    • 17.3.2. By Product
    • 17.3.3. By Stages
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Stages
    • 17.4.4. By End User
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis

18. South Asia Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Thailand
      • 18.3.1.3. Indonesia
      • 18.3.1.4. Malaysia
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Product
    • 18.3.3. By Stages
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Stages
    • 18.4.4. By End User
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis

19. East Asia Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 19.3.1. By Country
      • 19.3.1.1. China
      • 19.3.1.2. Japan
      • 19.3.1.3. South Korea
    • 19.3.2. By Product
    • 19.3.3. By Stages
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Stages
    • 19.4.4. By End User
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis

20. Oceania Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 20.3.1. By Country
      • 20.3.1.1. Australia
      • 20.3.1.2. New Zealand
    • 20.3.2. By Product
    • 20.3.3. By Stages
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Stages
    • 20.4.4. By End User
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis

21. Middle East and Africa Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

  • 21.1. Introduction
  • 21.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 21.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 21.3.1. By Country
      • 21.3.1.1. GCC Countries
      • 21.3.1.2. Northern Africa
      • 21.3.1.3. South Africa
      • 21.3.1.4. Turkey
      • 21.3.1.5. Rest of Middle East and Africa
    • 21.3.2. By Product
    • 21.3.3. By Stages
    • 21.3.4. By End User
  • 21.4. Market Attractiveness Analysis
    • 21.4.1. By Country
    • 21.4.2. By Product
    • 21.4.3. By Stages
    • 21.4.4. By End User
  • 21.5. Key Market Participants - Intensity Mapping
  • 21.6. Drivers and Restraints - Impact Analysis

22. Country Level Pressure Ulcer Devices Market Analysis 2022 & 2032

  • 22.1. Introduction
    • 22.1.1. Market Value Proportion Analysis, By Key Countries
    • 22.1.2. Global Vs. Country Growth Comparison
  • 22.2. U.S. Pressure Ulcer Devices Market Analysis
    • 22.2.1. By Product
    • 22.2.2. By Stages
    • 22.2.3. By End User
  • 22.3. Canada Pressure Ulcer Devices Market Analysis
    • 22.3.1. By Product
    • 22.3.2. By Stages
    • 22.3.3. By End User
  • 22.4. Mexico Pressure Ulcer Devices Market Analysis
    • 22.4.1. By Product
    • 22.4.2. By Stages
    • 22.4.3. By End User
  • 22.5. Brazil Pressure Ulcer Devices Market Analysis
    • 22.5.1. By Product
    • 22.5.2. By Stages
    • 22.5.3. By End User
  • 22.6. Germany Pressure Ulcer Devices Market Analysis
    • 22.6.1. By Product
    • 22.6.2. By Stages
    • 22.6.3. By End User
  • 22.7. Italy Pressure Ulcer Devices Market Analysis
    • 22.7.1. By Product
    • 22.7.2. By Stages
    • 22.7.3. By End User
  • 22.8. France Pressure Ulcer Devices Market Analysis
    • 22.8.1. By Product
    • 22.8.2. By Stages
    • 22.8.3. By End User
  • 22.9. U.K. Pressure Ulcer Devices Market Analysis
    • 22.9.1. By Product
    • 22.9.2. By Stages
    • 22.9.3. By End User
  • 22.10. Spain Pressure Ulcer Devices Market Analysis
    • 22.10.1. By Product
    • 22.10.2. By Stages
    • 22.10.3. By End User
  • 22.11. BENELUX Pressure Ulcer Devices Market Analysis
    • 22.11.1. By Product
    • 22.11.2. By Stages
    • 22.11.3. By End User
  • 22.12. Russia Pressure Ulcer Devices Market Analysis
    • 22.12.1. By Product
    • 22.12.2. By Stages
    • 22.12.3. By End User
  • 22.13. China Pressure Ulcer Devices Market Analysis
    • 22.13.1. By Product
    • 22.13.2. By Stages
    • 22.13.3. By End User
  • 22.14. Japan Pressure Ulcer Devices Market Analysis
    • 22.14.1. By Product
    • 22.14.2. By Stages
    • 22.14.3. By End User
  • 22.15. South Korea Pressure Ulcer Devices Market Analysis
    • 22.15.1. By Product
    • 22.15.2. By Stages
    • 22.15.3. By End User
  • 22.16. India Pressure Ulcer Devices Market Analysis
    • 22.16.1. By Product
    • 22.16.2. By Stages
    • 22.16.3. By End User
  • 22.17. Thailand Pressure Ulcer Devices Market Analysis
    • 22.17.1. By Product
    • 22.17.2. By Stages
    • 22.17.3. By End User
  • 22.18. Indonesia Pressure Ulcer Devices Market Analysis
    • 22.18.1. By Product
    • 22.18.2. By Stages
    • 22.18.3. By End User
  • 22.19. Malaysia Pressure Ulcer Devices Market Analysis
    • 22.19.1. By Product
    • 22.19.2. By Stages
    • 22.19.3. By End User
  • 22.20. Australia Pressure Ulcer Devices Market Analysis
    • 22.20.1. By Product
    • 22.20.2. By Stages
    • 22.20.3. By End User
  • 22.21. New Zealand Pressure Ulcer Devices Market Analysis
    • 22.21.1. By Product
    • 22.21.2. By Stages
    • 22.21.3. By End User
  • 22.22. GCC Countries Pressure Ulcer Devices Market Analysis
    • 22.22.1. By Product
    • 22.22.2. By Stages
    • 22.22.3. By End User
  • 22.23. Turkey Pressure Ulcer Devices Market Analysis
    • 22.23.1. By Product
    • 22.23.2. By Stages
    • 22.23.3. By End User
  • 22.24. Northern Africa Pressure Ulcer Devices Market Analysis
    • 22.24.1. By Product
    • 22.24.2. By Stages
    • 22.24.3. By End User
  • 22.25. South Africa Pressure Ulcer Devices Market Analysis
    • 22.25.1. By Product
    • 22.25.2. By Stages
    • 22.25.3. By End User

23. Market Structure Analysis

  • 23.1. Market Analysis by Tier of Companies
  • 23.2. Market Share Analysis of Top Players
  • 23.3. Market Presence Analysis
    • 23.3.1. By Regional Footprint of Players
    • 23.3.2. Product Footprint by Players
    • 23.3.3. Channel Footprint by Players

24. Competition Analysis

  • 24.1. Competition Dashboard
  • 24.2. Competition Benchmarking
  • 24.3. Competition Deep Dive
    • 24.3.1. Stryker Corp.
      • 24.3.1.1. Overview
      • 24.3.1.2. Product Portfolio
      • 24.3.1.3. Key Financials
      • 24.3.1.4. Sales Footprint
      • 24.3.1.5. Analyst commentary
      • 24.3.1.6. Strategy Overview
        • 24.3.1.6.1. Marketing Strategy
        • 24.3.1.6.2. Product Strategy
        • 24.3.1.6.3. Channel Strategy
    • 24.3.2. Smith & Nephew Plc.
      • 24.3.2.1. Overview
      • 24.3.2.2. Product Portfolio
      • 24.3.2.3. Key Financials
      • 24.3.2.4. Sales Footprint
      • 24.3.2.5. Analyst commentary
      • 24.3.2.6. Strategy Overview
        • 24.3.2.6.1. Marketing Strategy
        • 24.3.2.6.2. Product Strategy
        • 24.3.2.6.3. Channel Strategy
    • 24.3.3. Hill-Rom Services Inc.
      • 24.3.3.1. Overview
      • 24.3.3.2. Product Portfolio
      • 24.3.3.3. Key Financials
      • 24.3.3.4. Sales Footprint
      • 24.3.3.5. Analyst commentary
      • 24.3.3.6. Strategy Overview
        • 24.3.3.6.1. Marketing Strategy
        • 24.3.3.6.2. Product Strategy
        • 24.3.3.6.3. Channel Strategy
    • 24.3.4. Paramount Bed Holdings Co., Ltd.
      • 24.3.4.1. Overview
      • 24.3.4.2. Product Portfolio
      • 24.3.4.3. Key Financials
      • 24.3.4.4. Sales Footprint
      • 24.3.4.5. Analyst commentary
      • 24.3.4.6. Strategy Overview
        • 24.3.4.6.1. Marketing Strategy
        • 24.3.4.6.2. Product Strategy
        • 24.3.4.6.3. Channel Strategy
    • 24.3.5. ArjoHuntleigh
      • 24.3.5.1. Overview
      • 24.3.5.2. Product Portfolio
      • 24.3.5.3. Key Financials
      • 24.3.5.4. Sales Footprint
      • 24.3.5.5. Analyst commentary
      • 24.3.5.6. Strategy Overview
        • 24.3.5.6.1. Marketing Strategy
        • 24.3.5.6.2. Product Strategy
        • 24.3.5.6.3. Channel Strategy
    • 24.3.6. Talley Group Limited
      • 24.3.6.1. Overview
      • 24.3.6.2. Product Portfolio
      • 24.3.6.3. Key Financials
      • 24.3.6.4. Sales Footprint
      • 24.3.6.5. Analyst commentary
      • 24.3.6.6. Strategy Overview
        • 24.3.6.6.1. Marketing Strategy
        • 24.3.6.6.2. Product Strategy
        • 24.3.6.6.3. Channel Strategy
    • 24.3.7. Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
      • 24.3.7.1. Overview
      • 24.3.7.2. Product Portfolio
      • 24.3.7.3. Key Financials
      • 24.3.7.4. Sales Footprint
      • 24.3.7.5. Analyst commentary
      • 24.3.7.6. Strategy Overview
        • 24.3.7.6.1. Marketing Strategy
        • 24.3.7.6.2. Product Strategy
        • 24.3.7.6.3. Channel Strategy
    • 24.3.8. Apex Medical Corp.
      • 24.3.8.1. Overview
      • 24.3.8.2. Product Portfolio
      • 24.3.8.3. Key Financials
      • 24.3.8.4. Sales Footprint
      • 24.3.8.5. Analyst commentary
      • 24.3.8.6. Strategy Overview
        • 24.3.8.6.1. Marketing Strategy
        • 24.3.8.6.2. Product Strategy
        • 24.3.8.6.3. Channel Strategy
    • 24.3.9. Medtronic
      • 24.3.9.1. Overview
      • 24.3.9.2. Product Portfolio
      • 24.3.9.3. Key Financials
      • 24.3.9.4. Sales Footprint
      • 24.3.9.5. Analyst commentary
      • 24.3.9.6. Strategy Overview
        • 24.3.9.6.1. Marketing Strategy
        • 24.3.9.6.2. Product Strategy
        • 24.3.9.6.3. Channel Strategy
    • 24.3.10. PROMA REHA, s. r. o.
      • 24.3.10.1. Overview
      • 24.3.10.2. Product Portfolio
      • 24.3.10.3. Key Financials
      • 24.3.10.4. Sales Footprint
      • 24.3.10.5. Analyst commentary
      • 24.3.10.6. Strategy Overview
        • 24.3.10.6.1. Marketing Strategy
        • 24.3.10.6.2. Product Strategy
        • 24.3.10.6.3. Channel Strategy
    • 24.3.11. Linet spol. S R.O.
      • 24.3.11.1. Overview
      • 24.3.11.2. Product Portfolio
      • 24.3.11.3. Key Financials
      • 24.3.11.4. Sales Footprint
      • 24.3.11.5. Analyst commentary
      • 24.3.11.6. Strategy Overview
        • 24.3.11.6.1. Marketing Strategy
        • 24.3.11.6.2. Product Strategy
        • 24.3.11.6.3. Channel Strategy
    • 24.3.12. DARCO International
      • 24.3.12.1. Overview
      • 24.3.12.2. Product Portfolio
      • 24.3.12.3. Key Financials
      • 24.3.12.4. Sales Footprint
      • 24.3.12.5. Analyst commentary
      • 24.3.12.6. Strategy Overview
        • 24.3.12.6.1. Marketing Strategy
        • 24.3.12.6.2. Product Strategy
        • 24.3.12.6.3. Channel Strategy
    • 24.3.13. DeRoyal Industries
      • 24.3.13.1. Overview
      • 24.3.13.2. Product Portfolio
      • 24.3.13.3. Key Financials
      • 24.3.13.4. Sales Footprint
      • 24.3.13.5. Analyst commentary
      • 24.3.13.6. Strategy Overview
        • 24.3.13.6.1. Marketing Strategy
        • 24.3.13.6.2. Product Strategy
        • 24.3.13.6.3. Channel Strategy
    • 24.3.14. BSN Medical (Essity)
      • 24.3.14.1. Overview
      • 24.3.14.2. Product Portfolio
      • 24.3.14.3. Key Financials
      • 24.3.14.4. Sales Footprint
      • 24.3.14.5. Analyst commentary
      • 24.3.14.6. Strategy Overview
        • 24.3.14.6.1. Marketing Strategy
        • 24.3.14.6.2. Product Strategy
        • 24.3.14.6.3. Channel Strategy
    • 24.3.15. Molnlycke Health Care
      • 24.3.15.1. Overview
      • 24.3.15.2. Product Portfolio
      • 24.3.15.3. Key Financials
      • 24.3.15.4. Sales Footprint
      • 24.3.15.5. Analyst commentary
      • 24.3.15.6. Strategy Overview
        • 24.3.15.6.1. Marketing Strategy
        • 24.3.15.6.2. Product Strategy
        • 24.3.15.6.3. Channel Strategy
    • 24.3.16. TrueKAST (Wound Kair Concepts)
      • 24.3.16.1. Overview
      • 24.3.16.2. Product Portfolio
      • 24.3.16.3. Key Financials
      • 24.3.16.4. Sales Footprint
      • 24.3.16.5. Analyst commentary
      • 24.3.16.6. Strategy Overview
        • 24.3.16.6.1. Marketing Strategy
        • 24.3.16.6.2. Product Strategy
        • 24.3.16.6.3. Channel Strategy
    • 24.3.17. Thuasne SAS
      • 24.3.17.1. Overview
      • 24.3.17.2. Product Portfolio
      • 24.3.17.3. Key Financials
      • 24.3.17.4. Sales Footprint
      • 24.3.17.5. Analyst commentary
      • 24.3.17.6. Strategy Overview
        • 24.3.17.6.1. Marketing Strategy
        • 24.3.17.6.2. Product Strategy
        • 24.3.17.6.3. Channel Strategy
    • 24.3.18. DJO Global
      • 24.3.18.1. Overview
      • 24.3.18.2. Product Portfolio
      • 24.3.18.3. Key Financials
      • 24.3.18.4. Sales Footprint
      • 24.3.18.5. Analyst commentary
      • 24.3.18.6. Strategy Overview
        • 24.3.18.6.1. Marketing Strategy
        • 24.3.18.6.2. Product Strategy
        • 24.3.18.6.3. Channel Strategy
    • 24.3.19. ORTHOSERVICE AG
      • 24.3.19.1. Overview
      • 24.3.19.2. Product Portfolio
      • 24.3.19.3. Key Financials
      • 24.3.19.4. Sales Footprint
      • 24.3.19.5. Analyst commentary
      • 24.3.19.6. Strategy Overview
        • 24.3.19.6.1. Marketing Strategy
        • 24.3.19.6.2. Product Strategy
        • 24.3.19.6.3. Channel Strategy
    • 24.3.20. Breg, Inc.
      • 24.3.20.1. Overview
      • 24.3.20.2. Product Portfolio
      • 24.3.20.3. Key Financials
      • 24.3.20.4. Sales Footprint
      • 24.3.20.5. Analyst commentary
      • 24.3.20.6. Strategy Overview
        • 24.3.20.6.1. Marketing Strategy
        • 24.3.20.6.2. Product Strategy
        • 24.3.20.6.3. Channel Strategy
    • 24.3.21. Advanced Orthopaedics
      • 24.3.21.1. Overview
      • 24.3.21.2. Product Portfolio
      • 24.3.21.3. Key Financials
      • 24.3.21.4. Sales Footprint
      • 24.3.21.5. Analyst commentary
      • 24.3.21.6. Strategy Overview
        • 24.3.21.6.1. Marketing Strategy
        • 24.3.21.6.2. Product Strategy
        • 24.3.21.6.3. Channel Strategy
    • 24.3.22. ALGEOS
      • 24.3.22.1. Overview
      • 24.3.22.2. Product Portfolio
      • 24.3.22.3. Key Financials
      • 24.3.22.4. Sales Footprint
      • 24.3.22.5. Analyst commentary
      • 24.3.22.6. Strategy Overview
        • 24.3.22.6.1. Marketing Strategy
        • 24.3.22.6.2. Product Strategy
        • 24.3.22.6.3. Channel Strategy
    • 24.3.23. Hollister Incorporated
      • 24.3.23.1. Overview
      • 24.3.23.2. Product Portfolio
      • 24.3.23.3. Key Financials
      • 24.3.23.4. Sales Footprint
      • 24.3.23.5. Analyst commentary
      • 24.3.23.6. Strategy Overview
        • 24.3.23.6.1. Marketing Strategy
        • 24.3.23.6.2. Product Strategy
        • 24.3.23.6.3. Channel Strategy
    • 24.3.24. ConvaTec Group plc
      • 24.3.24.1. Overview
      • 24.3.24.2. Product Portfolio
      • 24.3.24.3. Key Financials
      • 24.3.24.4. Sales Footprint
      • 24.3.24.5. Analyst commentary
      • 24.3.24.6. Strategy Overview
        • 24.3.24.6.1. Marketing Strategy
        • 24.3.24.6.2. Product Strategy
        • 24.3.24.6.3. Channel Strategy
    • 24.3.25. Coloplast A/S
      • 24.3.25.1. Overview
      • 24.3.25.2. Product Portfolio
      • 24.3.25.3. Key Financials
      • 24.3.25.4. Sales Footprint
      • 24.3.25.5. Analyst commentary
      • 24.3.25.6. Strategy Overview
        • 24.3.25.6.1. Marketing Strategy
        • 24.3.25.6.2. Product Strategy
        • 24.3.25.6.3. Channel Strategy
    • 24.3.26. Medline Industries Inc.
      • 24.3.26.1. Overview
      • 24.3.26.2. Product Portfolio
      • 24.3.26.3. Key Financials
      • 24.3.26.4. Sales Footprint
      • 24.3.26.5. Analyst commentary
      • 24.3.26.6. Strategy Overview
        • 24.3.26.6.1. Marketing Strategy
        • 24.3.26.6.2. Product Strategy
        • 24.3.26.6.3. Channel Strategy
    • 24.3.27. Invacare Corporation
      • 24.3.27.1. Overview
      • 24.3.27.2. Product Portfolio
      • 24.3.27.3. Key Financials
      • 24.3.27.4. Sales Footprint
      • 24.3.27.5. Analyst commentary
      • 24.3.27.6. Strategy Overview
        • 24.3.27.6.1. Marketing Strategy
        • 24.3.27.6.2. Product Strategy
        • 24.3.27.6.3. Channel Strategy

25. Assumptions and Acronyms Used

26. Research Methodology